<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-128774</identifier>
<setSpec>1695-4033</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Respiratory treatments in neuromuscular disease</dc:title>
<dc:description xml:lang="en">In a previous article, a review was presented of the respiratory pathophysiology of the patient with neuromuscular disease, as well as their clinical evaluation and the major complications causing pulmonary deterioration. This article presents the respiratory treatments required to preserve lung function in neuromuscular disease as long as possible, as well as in special situations (respiratory infections, spinal curvature surgery, etc.). Special emphasis is made on the use of non-invasive ventilation, which is changing the natural history of many of these diseases. The increase in survival and life expectancy of these children means that they can continue their clinical care in adult units. The transition from pediatric care must be an active, timely and progressive process. It may be slightly stressful for the patient before the adaptation to this new environment, with multidisciplinary care always being maintained (AU)</dc:description>
<dc:creator>Asensio de la Cruz, O</dc:creator>
<dc:creator>Salcedo Posadas, A</dc:creator>
<dc:creator>Torrent Vernetta, A</dc:creator>
<dc:creator>Cols Roig, M</dc:creator>
<dc:creator>Martínez Carrasco, C</dc:creator>
<dc:creator>Sardon Prado, O</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Revisadas en un artículo anterior la fisiopatología respiratoria del enfermo neuromuscular (ENM), así como su evaluación clínica y las principales complicaciones causantes de su deterioro pulmonar, en el presente artículo se describen los tratamientos respiratorios necesarios para preservar la función pulmonar del ENM durante el mayor tiempo posible, así como en situaciones especiales (infecciones respiratorias, cirugía de escoliosis, etc.). Se hace especial hincapié en la utilidad de la ventilación no invasiva cuyo uso está cambiando la historia natural de muchas de estas enfermedades. La prolongación de la vida en estos niños permite que lleguen a las unidades de neumología de adultos para proseguir su atención. La transición desde la pediatría debe ser un proceso activo, progresivo en el tiempo y poco estresante para el paciente ante la adaptación a ese nuevo entorno, manteniendo siempre una atención multidisciplinar (AU)</dc:description>
<dc:source>An Pediatr (Barc);81(4): 259-259[e1-e9], oct. 2014. tab, ilus</dc:source>
<dc:identifier>ibc-128774</dc:identifier>
<dc:title xml:lang="es">Tratamientos respiratorios en la enfermedad neuromuscular</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d34190^s22053</dc:subject>
<dc:subject>^d34190^s22067</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d55022^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d9660^s22053</dc:subject>
<dc:subject>^d12552^s22053</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d9660^s22067</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d12552^s22012</dc:subject>
<dc:subject>^d12552^s22067</dc:subject>
<dc:subject>^d55022^s22074</dc:subject>
<dc:subject>^d22949^s22067</dc:subject>
<dc:subject>^d11443^s22012</dc:subject>
<dc:subject>^d11443^s22067</dc:subject>
<dc:subject>^d11443^s22053</dc:subject>
<dc:subject>^d22949^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>201410</dc:date>
</metadata>
</record>
</ibecs-document>
